Park, Hankum http://orcid.org/0000-0001-5795-3249
Hundley, Frances V. http://orcid.org/0000-0001-9469-301X
Yu, Qing
Overmyer, Katherine A. http://orcid.org/0000-0002-1929-1229
Brademan, Dain R.
Serrano, Lia
Paulo, Joao A. http://orcid.org/0000-0002-4291-413X
Paoli, Julia C. http://orcid.org/0000-0001-8266-1766
Swarup, Sharan
Coon, Joshua J. http://orcid.org/0000-0002-0004-8253
Gygi, Steven P. http://orcid.org/0000-0001-7626-0034
Wade Harper, J. http://orcid.org/0000-0002-6944-7236
Funding for this research was provided by:
H.P. was the recipient of a postdoctoral fellowship from the Edward R. and Anne G. Lefler Center for the Study of Neurodegenerative Disorders.
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK098285)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM108538)
U.S. Department of Health & Human Services | National Institutes of Health (R01GM067945)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS083524, NS110395)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Aligning Science Across Parkinson’s
Article History
Received: 21 March 2022
Accepted: 5 October 2022
First Online: 16 October 2022
Competing interests
: J.W.H. is a consultant and founder of Caraway Therapeutics and is a founding board member of Interline Therapeutics. J.J.C. and S.P.G. are consultants for Thermo Fischer Scientific. The remaining authors declare no competing interests.